Erratum: A comprehensive survey of cancer risks in extended families (Genetics in Medicine (2012) 14 (107-114) DOI: 10.1038/gim.2011.2);A comprehensive survey of cancer risks in extended families

Genetics in Medicine

Volumn 14, Issue 1, 2012, Pages 107-114

  Teerlink, Craig C ^a   Albright, Frederick S ^b   Lins, Lauro ^c   Cannon Albright, Lisa A ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cancer; epidemiology; familiality; heritability; relative risk

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CANCER SUSCEPTIBILITY; FAMILY; FEMALE; GENEALOGY; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; POPULATION RESEARCH; RELATIVE; UNITED STATES;

EID: 84855561009     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2012.30     Document Type: Erratum

References (39)

1. Cannon-Albright LA, Thomas A, Goldgar DE, et al. Familiality of cancer in Utah. Cancer Res 1994;54:2378-2385. (Pubitemid 24138728)
2. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-1608. (Pubitemid 24336346)
3. Kerber RA, O'Brien E. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 2005;103:1906-1915. (Pubitemid 40563264)
4. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1:e65.
5. Hemminki K, Sundquist J, Brandt A. Familial mortality and familial incidence in cancer. J Clin Oncol 2011;29:712-718.
6. Hemminki K, Ji J, Brandt A, Mousavi SM, Sundquist J. The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. Int J Cancer 2010;126:2259-2267.
7. Hiripi E, Bermejo JL, Sundquist J, Hemminki K. Familial gastrointestinal carcinoid tumours and associated cancers. Ann Oncol 2009;20:950-954.
8. Bermejo JL, Sundquist J, Hemminki K. Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden. Int J Cancer 2009;124: 2166-2171.
9. Brandt A, Bermejo JL, Sundquist J, Hemminki K. Age of onset in familial cancer. Ann Oncol 2008;19:2084-2088.
10. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002;99:260-266. (Pubitemid 34309484)
11. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001;92: 144-150. (Pubitemid 32187044)
12. Vaittinen P, Hemminki K. Familial cancer risks in offspring from discordant parental cancers. Int J Cancer 1999;81:12-19. (Pubitemid 29124189)
13. Skolnick MH. The Utah genealogical database: a resource for genetic epidemiology. In: Cairns J, Lyon JL, Skolnick M (eds). Banbury Report No. 4: Cancer Incidence in Defined Populations. Cold Spring Harbor Laboratories: New York, 1980:285-297.
14. Hill J. A survey of cancer sites by kinship in the Utah Mormon population. In: Cairns J, Lyon JL, Skolnick M (eds). Banbury Report No. 4: Cancer Incidence in Defined Populations. Cold Spring Harbor Laboratories: New York, NY, 1980:299-318.
15. Cannon LA, Bishop DT, Skolnick M, Hunt S, Lyon L, Smart CR. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1982;1:47-70.
16. Albright LA, Schwab A, Camp NJ, Farnham JS, Thomas A. Population-based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases. Prostate 2005;64:347-355. (Pubitemid 41193247)
17. Larson AA, Leachman SA, Eliason MJ, Cannon-Albright LA. Population-based assessment of non-melanoma cancer risk in relatives of cutaneous melanoma probands. J Invest Dermatol 2007;127:183-188. (Pubitemid 46005677)
18. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71. (Pubitemid 24345325)
19. Tavtigian SV, Simard J, Rommens J, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996;12:333-337. (Pubitemid 26080098)
20. Kamb A, Shattuck-Eidens D, Eeles R, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994;8:23-26.
21. Tavtigian SV, Simard J, Teng DH, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001;27:172-180. (Pubitemid 32157444)
22. Tashjian RZ, Farnham JM, Albright FS, Teerlink CC, Cannon-Albright LA. Evidence for an inherited predisposition contributing to the risk for rotator cuff disease. J Bone Joint Surg Am 2009;91:1136-1142.
23. Teerlink CC, Hegewald MJ, Cannon-Albright LA. A genealogical assessment of heritable predisposition to asthma mortality. Am J Respir Crit Care Med 2007;176:865-870. (Pubitemid 350097075)
24. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA. Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation 2004;110:3143-3148. (Pubitemid 39492011)
25. Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG. A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg 2003;99:637-643. (Pubitemid 37159039)
26. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008;197: 18-24. (Pubitemid 351263461)
27. Weires MB, Tausch B, Haug PJ, Edwards CQ, Wetter T, Cannon-Albright LA. Familiality of diabetes mellitus. Exp Clin Endocrinol Diabetes 2007;115: 634-640. (Pubitemid 350220402)
28. Maul JS, Burt RW, Cannon-Albright LA. A familial component to human rectal cancer, independent of colon cancer risk. Clin Gastroenterol Hepatol 2007;5:1080-1084.
29. Blumenthal DT, Cannon-Albright LA. Familiality in brain tumors. Neurology 2008;71:1015-1020.
30. Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA. Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer 2005;117:655-661. (Pubitemid 41504555)
31. McLellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 1984;36:836-857. (Pubitemid 14030098)
32. Jorde LB. Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet 1989;53(Pt 4):339-355. (Pubitemid 19282107)
33. Fritz A, Percy C, Jack A, et al. (eds). International Classification of Diseases for Oncology, 3rd edn. World Health Organization: Geneva, Switzerland, 2000.
34. Hemminki K, Chen B. Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database. Prostate 2005;65:188-194. (Pubitemid 41362286)
35. Hemminki K, Li X. Association of brain tumours with other neoplasms in families. Eur J Cancer 2004;40:253-259. (Pubitemid 38077028)
36. Ji J, Hemminki K. Second gastric cancers among patients with primary sporadic and familial cancers in Sweden. Gut 2006;55:896-898. (Pubitemid 43764566)
37. Hemminki K, Sundquist J, Brandt A. Incidence and mortality in epithelial ovarian cancer by family history of any cancer. Cancer 2011;117:3972-3980.
38. Hemminki K, Aaltonen L, Li X. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma. Cancer 2003;97: 2432-2439. (Pubitemid 36542482)
39. Bermejo JL, Sundquist J, Hemminki K. Bladder cancer in cancer patients: population-based estimates from a large Swedish study. Br J Cancer 2009;101:1091-1099.